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Rationale Reflection impulsivity-a failure to gather and evaluate information before making a decision-is a 
critical component of risk-taking and substance use behaviours, which are highly prevalent during 
adolescence. Objectives and methods The Information Sampling Test was used to assess reflection 
impulsivity in 175 adolescents (mean age 18.3, range 16.5-20; 55% female)-48 cannabis users (2.3 years 
use, 10.8 days/month), 65 alcohol users, and 62 non-substance-using controls-recruited from a 
longitudinal cohort and from the general community and matched for education and IQ. Cannabis and 
alcohol users were matched on levels of alcohol consumption. Results Cannabis users sampled to the 
lowest degree of certainty before making a decision on the task. Group differences remained significant 
after controlling for relevant substance use and clinical confounds (e.g., anxiety, depressive symptoms, 
alcohol, and ecstasy use). Poor performance on multiple IST indices was associated with an earlier age 
of onset of regular cannabis use and greater duration of exposure to cannabis, after controlling for recent 
use. Alcohol users did not differ from controls on any IST measure. Conclusions Exposure to cannabis 
during adolescence is associated with increased risky and impulsive decision making, with users 
adopting strategies with higher levels of uncertainty and inefficient utilisation of information. The young 
cannabis users did show sensitivity to losses, suggesting that greater impulsivity early in their drug using 
career is more evident when there is a lack of negative consequences. This provides a window of 
opportunity for intervention before the onset of cannabis dependence. 
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Rationale Reflection impulsivity – a failure to gather and evaluate information before 
making a decision – is a critical component of risk-taking and substance use 
behaviours, which are highly prevalent during adolescence.  
Objectives and Methods The Information Sampling Test was used to assess reflection 
impulsivity in 175 adolescents (mean age 18.3, range 16.5-20; 55% female) – 48 
cannabis users (2.3 years use, 10.8 days/month), 65 alcohol users and 62 non-
substance-using controls – recruited from a longitudinal cohort and from the general 
community and matched for education and IQ. Cannabis and alcohol users were 
matched on levels of alcohol consumption.  
Results Cannabis users sampled to the lowest degree of certainty before making a 
decision on the task. Group differences remained significant after controlling for 
relevant substance use and clinical confounds (e.g., anxiety, depressive symptoms, 
alcohol and ecstasy use). Poor performance on multiple IST indices was associated 
with an earlier age of onset of regular cannabis use and greater duration of exposure to 
cannabis, after controlling for recent use. Alcohol users did not differ from controls on 
any IST measure.  
Conclusions Exposure to cannabis during adolescence is associated with increased 
risky and impulsive decision making, with users adopting strategies with higher levels 
of uncertainty and inefficient utilisation of information. The young cannabis users did 
show sensitivity to losses, suggesting that greater impulsivity early in their drug using 
career is more evident when there is a lack of negative consequences.  This provides a 
window of opportunity for intervention before the onset of cannabis dependence.  







Impulsivity, risky decision making and deficits in inhibitory control are thought 
to underlie addictive behaviours (Goldstein and Volkow 2002; Jentsch and Taylor 
1999; Yücel et al. 2007) and play a critical role in the maintenance and relapse to 
substance use (Garavan and Stout 2005).  Adult long-term cannabis users have been 
shown to exhibit deficits in various inhibitory processing measures (e.g., Stroop, 
Go/NoGo) (Battisti et al. 2010; Bolla et al. 2002; Bolla et al. 2005; Eldreth et al. 
2004; Gruber and Yurgelun-Todd 2005; Hester et al. 2009; Novaes et al. 2008; 
Solowij et al. 2002; Tapert et al. 2007).  Poorer performance has been associated with 
parameters of cannabis use such as duration, dosage and age of onset of use (Battisti 
et al. 2010; Bolla et al. 2002; Novaes et al. 2008; Solowij et al. 2002).  Typically, 
users show impairment in the ability to self-monitor behaviour, having low error 
awareness (Hester et al. 2009) and increased error rates (Battisti et al. 2010).  In some 
studies where users have shown comparable performance to controls, this has been 
accompanied by altered electrophysiology or increased activation of brain regions 
indicating that users may require increased neural effort in order to maintain adequate 
performance levels (Battisti et al. 2010; Hester et al. 2009; Tapert et al. 2007).   
Cannabis-related deficits have been identified in a small number of studies that 
used tasks specifically designed to measure risky or impulsive decision making, such 
as the Matching Familiar Figures Task (MFFT) (Kagan 1966) or the Iowa Gambling 
Task (IGT; Bechara et al. 1994) (e.g., Fridberg et al. 2010; Hermann et al. 2009; 
Lamers et al. 2006; Wesley et al. 2011; Whitlow et al. 2004).  Whitlow et al. (2004) 
found that long-term heavy cannabis users made decisions that led to greater 




that the imbalance between perceived rewards and punishments may contribute to 
ongoing drug use.  Fridberg et al. (2010) enlarged the small sample of Whitlow et al. 
(2004) and applied mathematical modeling to the data to show that cannabis users’ 
choices were characterized by greater sensitivity to gains, insensitivity to losses, 
greater dependence upon recent outcomes, and less consistency with expected 
payoffs.  Differences between cannabis users and controls in motivational, learning 
and memory, and behavioural control processes were thought to underlie their 
characteristic performance on the IGT.  In a recent imaging study, Wesley et al. 
(2011) showed less activation in cannabis users relative to controls in regions 
subserving complex decision making and a lack of correlation between performance 
over time and functional response to losses, indicative of insensitivity to feedback 
during strategy development in the users.  
Impulsivity is a multi-factored concept comprising attentional, predecisional 
reflection and disinhibition dimensions (Dickman 1993), and includes both motor and 
cognitive factors (Evenden 1999a). The high demands on visual search, working 
memory and strategy use of tasks such as the MFFT and the IGT may not be 
capturing information specific to impulsive or risky decision making in cannabis 
users, since the former processes are also known to be impaired in cannabis users 
(Ilan et al. 2004; Jager et al. 2006; Kanayama et al. 2004; Solowij and Battisti 2008).  
The cognitive construct of reflection impulsivity specifically refers to the tendency to 
gather and evaluate information prior to decision making (Kagan 1966), which 
contrasts with ‘the tendency to make an impulsive selection of a solution’ (Kagan 
1965, p.609).  The Information Sampling Task (IST) from the Cambridge 
Neuropsychological Test Automated Battery (CANTAB) was designed to specifically 




to be a purer measure than previous such tasks (e.g., the MFFT or the IGT).  Rather 
than relying on speed-accuracy indices, the IST measures reflection impulsivity by 
calculating the probability of the subject selecting the correct answer at the point of 
decision on the basis of their sampling of information prior to making that decision, 
and the IST has a low working memory load.  
Clark et al. (2009) were the first to examine reflection impulsivity by means of 
the IST in current and former ecstasy users compared to young adult cannabis users 
with no lifetime use of ecstasy and to non-drug-using controls.  Despite the fact that 
the primary aim of their study was to examine impulsivity in regular ecstasy users 
(n=46), they found that the considerably smaller group of current cannabis users 
(n=15) but not ecstasy users were impaired.  The cannabis users sampled significantly 
less information on the task and tolerated a lower level of certainty in their decision 
making than did controls, while current and former ecstasy users did not differ from 
controls.  In an earlier study, Clark et al. (2006) reported that current amphetamine 
and opiate users also sampled less information than controls and had a lower 
probability of making a correct response on the task.  Around half of the drug users in 
the study were also using cannabis.  As such, the IST may be particularly sensitive to 
the effects of cannabis on information sampling and impulsive decision making.   
No studies to date have examined reflection impulsivity in adolescent cannabis 
users.  Risky decision making and impulsivity are also characteristic of adolescence; 
adolescents show the capability to reflect on risky decisions but often choose not to, 
and this may underlie substance use and other risky behaviours (Steinberg 2007).  
Adolescence is the primary period for experimentation and subsequent initiation of 
regular cannabis use in particular (Copeland and Swift 2009; Jacobus et al. 2009).  




may be especially vulnerable to the adverse effects of exposure to cannabis (Cha et al. 
2006; Lubman et al. 2007; Schepis et al. 2008; Schneider 2008; Yücel et al. 2007).  A 
growing literature has reported a range of cognitive deficits in adolescent cannabis 
users and greater adverse effects the earlier that cannabis use commences, particularly 
before the age of 17 years (Ehrenreich et al. 1999; Harvey et al. 2007; Huestegge et al. 
2002; Jacobsen et al. 2004; Jacobsen et al. 2007; Jacobus et al. 2009; Kempel et al. 
2003; Medina et al. 2007; Pope et al. 2003; Schwartz et al. 1989; Solowij and Battisti 
2008; Solowij et al. 2011). 
In this study, we examined the IST performance of adolescent cannabis users in 
relation to parameters of cannabis use such as quantity, frequency, duration and age of 
onset of use.  Since adolescent cannabis users often also drink alcohol (Copeland and 
Swift 2009), and tend to consume more alcohol than non-users (Chun et al. 2010), we 
also sought to determine the specificity of effects by comparing the cannabis group 
with an adolescent alcohol user group matched on monthly alcohol use, as well as 
with a non-user control group.  Finally, we had the opportunity to control for 
premorbid intellectual ability (obtained at entry to high school) and to examine its 





A total of 175 adolescent participants (mean age 18.3, SD=0.63) were recruited 
for this study, comprising 48 cannabis users, 65 alcohol users and 62 controls.  The 
majority of participants were recruited from the Wollongong Youth Study (WYS) – a 




regional high schools in the wider southern Sydney region of Australia (Heaven and 
Ciarrochi 2008).  Due to the small sample size of cannabis users recruited from this 
source (n=12), a newspaper advertisement was used to recruit an additional 36 
adolescent cannabis users to the study from the same demographic catchment as the 
WYS participants.  Externally recruited participants were matched on age, IQ and 
premorbid intellectual ability to the WYS sample.  They did not differ from the WYS 
cannabis or alcohol users on monthly alcohol consumption and a range of 
psychological factors as described below, but they were more entrenched in their 
cannabis use (greater frequency (p<0.001) and quantity (p<0.001) of cannabis use per 
month).  Full details of the sample are provided in Solowij et al. (2011).  
The study was fully approved by the University of Wollongong and South 
East Sydney and Illawarra Area Health Service Human Research Ethics Committee 
and conducted in accordance with the Declaration of Helsinki.  Participants provided 
written informed consent and were reimbursed AU$50 for their time and travel 
expenses.  
  
Measures of psychological functioning and intellectual ability 
Subjects were screened for potential psychological disorders using the Kessler 
Psychological Distress Scale K10 (Kessler et al. 2002) and structured interview 
assessed psychiatric, medical and neurological history.  Participants were excluded for 
any current psychiatric disorders, if they were currently in treatment for substance 
dependence, and if they had any history of head injury or serious medical conditions.  
Participants completed the State-Trait Anxiety Inventory (STAI; Spielberger 
1989), the Beck Depression Inventory (BDI; Beck et al. 1996) and the Apathy 




symptoms.  All participants completed the short form of the Wechsler Abbreviated 
Scale of Intelligence (WASI) to obtain a measure of current IQ.  Measures of 
premorbid intellectual ability were available for the majority of the sample (66.3%: 24 
cannabis users, 47 alcohol users, 45 controls) from standardised verbal and numerical 
ability tests administered by the Department of Education to all students during their 
first year of high school (at approximately age 12).   
 
Substance use characteristics of the sample 
Current and past substance use was assessed by structured interview that 
incorporated the Alcohol Use Disorders Identification Test (AUDIT; Allen et al. 
1997) and a TimeLine Follow Back procedure (TLFB; Sobell and Sobell 1992).  
Average frequency and quantity of cannabis and alcohol consumed per month were 
calculated from across these measures.  TLFB data informed of any other drug use in 
the past 30 days.  Cannabis users were also administered the Marijuana Withdrawal 
Checklist (MWC; adapted from Budney et al. 1999 and Vandrey et al. 2005) and the 
Severity of Dependence Scale (SDS; Swift et al. 1998) for cannabis.    
Cannabis and alcohol users were required to have used cannabis or alcohol at 
least twice/month for 6-12 months.  The majority were regular users (Table 2) but 
several participants were included in their respective samples despite a briefer period 
of exposure to either substance if use in recent months had been particularly frequent 
or heavy, or if they had less frequent use that had nevertheless been ongoing for >18 
months.  This policy was applied to be inclusive as possible for participants with 
available data and since such users would not qualify as non-user controls.  Similarly, 
participants were included in the control group if they reported ‘regular’ alcohol use 




more than 12 months (or if they drank at least twice/month but had only commenced 
doing so in the past 2 months, in which case they would not qualify for the alcohol 
user group).  Some participants in the alcohol and control groups had tried cannabis in 
their lifetime (29.2% of alcohol users and 8.1% of controls; maximum five 
occasions).   
All participants were asked not to consume cannabis, alcohol or any other 
illicit substances for at least 12 hours before testing and self-reported abstinence was 
supported by breath analysis (zero alcohol readings for the entire sample), urinalysis 
(for all illicit drugs) and saliva testing for delta-9-tetrahydrocannabinol (THC) using 
gas chromatography-mass spectrometry (Cozart Bioscience Ltd 2001-2009).  
Cannabis users reported a median 22.5 hours abstinence from cannabis.   The median 
carboxy-THC metabolite in urine for the cannabis using sample was 84ug/L [0-4335].  
No cannabinoid metabolites were detected in controls or alcohol users.  The median 
THC level in saliva in cannabis users was 0ng/ml [0-7.2].  THC may remain in the 
oral cavity for 24 hours or more after smoking with levels generally falling below 
1ng/ml 12-24 hours after smoking (Huestis and Cone 2004; Niedbala et al. 2001) but 
with much individual variability.  Salivary THC levels were below 1ng/ml in the vast 
majority of the current sample (82.6%; 54.3% had zero levels) and strong correlations 
between salivary THC or urinary cannabinoid levels and self-reported hours since last 
use (Spearman’s rho=-0.55, p<0.001 and rho=-0.70, p<0.001, respectively) provide 
good corroboration with self-reported abstinence from cannabis prior to testing. 
 
The Information Sampling Task (IST) 
Participants first completed a single practice trial, followed by 10 trials in each 




matrix of grey boxes with two larger coloured panels at the foot of the screen.  
Touching a grey box would immediately open that box to reveal one of the two 
colours displayed at the bottom of the screen.  Subjects were able to open boxes at 
their own rate with no time limit before deciding which of the two colours was in the 
majority of the 25 boxes.  According to manualised instructions and procedures 
described in Clark et al. (2006), they were told ‘it is entirely up to you how many 
boxes you open before making your decision’ and they indicated their decision by 
touching one of the two panels at the bottom of the screen.  At this point the 
remaining boxes were uncovered and one of two messages was presented: “Correct! 
You have won [x] points” or “Wrong! You have lost 100 points”.  In the ‘fixed win’ 
condition subjects could open any number of boxes to potentially gain 100 points and 
not lose any points.  In the ‘decreasing win’ condition, subjects lost 10 points for 
every box that they opened.  There was a variable delay of at least 1 second before the 
onset of the next trial. 
The primary performance outcome measures were the mean number of boxes 
opened per trial, the mean probability of being correct at the point of decision: 
P(Correct), and discrimination and sampling errors.  P(Correct) was the probability 
that the colour chosen by the subject at the point of decision would be correct, based 
only on the evidence available to the subject at the time (i.e., dependent on the amount 
of information they had sampled).  Discrimination errors occurred when the 
participant chose a colour that was not at that point in time in the majority, thus 
making a decision not logically based on the evidence available to them.  Sampling 
errors were the number of trials where the subject chose a colour that was not in the 
overall majority but was in the majority at the point of decision.  Mean box opening 




then opening the subsequent box), as was mean colour decision latency (the time 
elapsed between the start of a trial and the point at which the subject selects a colour 
that they believe to be in the overall majority).  
 
Statistical Analysis 
Data were analysed using SPSS version 16 using repeated measures (condition: 
Fixed vs Decreasing win x group) analysis of variance (rmANOVA) with follow up 
Tukey tests for group comparison on normally distributed variables.  Analysis of 
covariance (ANCOVA) was then conducted for normally distributed variables.  For 
variables that violated the Shapiro-Wilk test of normality, non-parametric Mann-
Whitney and Kruskal-Wallis follow up tests were employed examining fixed and 
decreasing win conditions separately.  Pearson correlations were performed for 
normally distributed variables and Spearman correlations for skewed variables to 




Demographics and Patterns of Substance Use 
Demographic and clinical characteristics of the sample are shown in Table 1.  
The three groups did not differ in current full scale IQ (F(2,174)=0.07, p=0.93) or 
premorbid verbal (F(2,116)=1.46, p=0.24) or numerical ability (F(2,115)=2.58, 
p=0.08).  While the groups differed significantly in age (F(2,174)=11.47, p<0.001), 
this was due to the precision with which we measured age (in portions of months).  
The mean age at assessment in each group was 18 years (Table 1) and, while minor 




outcome measures, we nevertheless included age as a covariate in our between-group 
analyses.  The gender ratio differed between groups (χ2(2)=10.24, p=0.006) with 
females overrepresented in the control group.  Group differences were observed on 
apathy scores (χ2(2)=14.80, p=0.001; cannabis users > alcohol users and controls), 
depressive symptoms (χ2(2)=10.43, p=0.005; cannabis users > controls) and state 
anxiety (χ2(2)=10.24, p=0.006; controls < cannabis users and alcohol users), but not 
trait anxiety (p=0.08).  Variables on which groups differed were included as 
covariates in the analyses. 
Table 2 shows the substance use characteristics of the sample.  The cannabis 
users first tried cannabis around age 15, with regular use commencing around age 
16.5.  They had used cannabis regularly for a mean 2.3 years and were currently using 
approximately 10 days per month.  After self-reported abstinence from cannabis for a 
median 22.5 h, the cannabis users reported a median score of 5 on the withdrawal 
scale from a possible 45-point maximum, indicating that withdrawal symptoms were 
of minor concern to participants during testing. The median score on the SDS 
suggests that this young sample were not yet dependent on cannabis. Cannabis users 
did not differ from alcohol users in frequency or quantity of alcohol consumed per 
month, but cannabis users had started drinking at an earlier age and had higher 
AUDIT scores.  Cannabis users smoked more tobacco cigarettes per day than either 
other group and alcohol users also smoked more than controls.  Cannabis users had 
used other illicit substances on more occasions than any other group but had never 
used these on a regular basis.  Thirteen cannabis users (27%) had used ecstasy in the 
past 30 days (0-3 pills consumed).  One alcohol user had consumed two ecstasy 
tablets in the past 30 days.  Other recent drug use in the cannabis group was modest 




hallucinogenic mushrooms in the past 30 days.  Cannabis users with and without 
recent other drug use were compared on their IST performance.  
 
Tables 1 and 2 about here 
 
IST Performance: P(Correct) and Number of Boxes Opened 
Analyses revealed a significant main effect of group for the probability of being 
correct at the point of decision (F(2,172)=6.02, p=0.003) and for the number of boxes 
opened per trial (F(2,172)=4.32, p=0.015), with cannabis users having a significantly 
lower P(Correct) score than both alcohol users (p=0.008) and controls (p=0.006), 
while the latter groups did not differ (p=0.99).  Cannabis users opened fewer boxes 
than alcohol users (p=0.012) but not controls (p=0.11), and the latter groups did not 
differ (p=0.63).  Table 3 shows P(Correct) and number of boxes opened for both fixed 
and decreasing win conditions.  In the fixed win condition, cannabis users sampled 
information to a point of 79% certainty while alcohol users and controls sampled to a 
point of 85% certainty.  This reduced for all groups in the decreasing win condition, 
with cannabis users sampling to a point of 68% certainty and alcohol users and 
controls 71% and 72%, respectively.  While there was a significant main effect of 
condition (F(1,172)=302.77, p<0.001), there was no significant condition by group 
interaction (p=0.24), with similar results for the number of boxes opened (main effect 
of condition: (F(1,172)= 354.08, p<0.001); condition by group interaction: p=0.57). 
 
Figure 1 and Table 3 about here 
 
We next used covariate analyses to control for variables that differed between 
groups. The main effect of group remained significant for P(Correct) after controlling 




(F(2,170)=6.06, p=0.003), hours since last consumption of alcohol (F(2,159)=4.90, 
p=0.009), age of first alcohol use (F(2,163)=5.02, p=0.008), cigarettes smoked per 
day (F(2,165)=3.31, p=0.03), apathy (F(2,171)=4.48, p=0.013), depressive symptoms 
(F(2,171)=5.23, p=0.006) and state anxiety (F(2,169)=7.28, p=0.001).  With all 
covariates in the model the main effect of group was F(2,146)=4.97, p=0.008, and 
apathy was the only significant covariate in the model (p=0.012).  Including age of 
onset of regular alcohol use as a covariate however, reduced the significance of the 
overall group difference for P(Correct) (F(2,143)=2.98, p=0.054).  The ages of onset 
of regular use of cannabis and of alcohol were highly correlated (Spearmans’ 
rho=0.49, p<0.001) and we show below that the effects observed on performance 
were associated with cannabis use and not with alcohol use. The same pattern of 
results was evident for the number of boxes opened when the above covariates were 
included in the model. 
 
IST Performance: Errors 
Table 3 shows that cannabis users’ task accuracy was impaired specifically in 
the fixed win condition, with more discrimination errors (χ2(2)=9.39, p=0.009) than 
alcohol users (Z=2.04, p<0.05) and controls (Z=3.04, p<0.01).  There were trends 
toward cannabis users making more discrimination errors in the decreasing win 
condition also (p=0.09), and toward more sampling errors in the fixed win condition 
(p=0.09).   
 
IST Performance: Latency measures 
As shown in Table 3, there were no significant differences between the three 




significantly different between the groups in the fixed condition only (χ2(2)=6.06, 
p=0.048), with cannabis users making faster colour decisions than both controls 
(Z=2.31, p<0.05) and alcohol users (Z=2.02, p<0.05).  
 
IST Performance Associations with Cannabis Use and Psychological Measures 
Correlations between primary substance use measures and IST performance 
measures are shown in Table 4.  The majority of associations between IST 
performance and cannabis use measures were found for age of onset and duration of 
cannabis use in the fixed win condition.  Earlier onset of first or regular use of 
cannabis was associated with lower P(Correct), fewer boxes opened, and more 
sampling errors in the fixed win condition.  An earlier age of onset of regular use was 
also associated with more discrimination errors and longer box opening latency in the 
fixed win condition.  A longer duration of regular use of cannabis was associated with 
lower P(Correct) scores, fewer boxes opened, more sampling errors, more 
discrimination errors and longer box opening latency in the fixed condition alone.   
 
Table 4 about here 
 
Greater frequency cannabis use was also associated with a lower probability of 
being correct at point of decision P(Correct) in the fixed condition alone, and greater 
frequency and quantity of cannabis use per month were positively correlated with 
discrimination errors in both fixed and decreasing win conditions.  Therefore, the 
more frequent and heavy the cannabis use, the more likely the subject was to choose a 
colour that was not in the majority at point of decision.  Greater quantity cannabis use 
was also significantly correlated with a longer box opening latency in the fixed 
condition.  Salivary THC levels correlated with only one IST measure: discrimination 




last use, and the only other measure to correlate with self-reported hours since last use 
was the mean colour decision latency in the decreasing win condition (rho=-0.49, 
p=0.005).  Urinary cannabinoid metabolite levels correlated inversely with P(correct), 
and positively with discrimination errors and box opening latency, all in the fixed win 
condition, and additionally with discrimination errors in the decreasing win condition.  
These results suggest that recent cannabis use and residues may also exert an 
influence on reflection impulsivity and decision making.  
No IST measures were associated with cannabis dependence or withdrawal 
scores, depressive symptom scores, state or trait anxiety, apathy or AUDIT scores (all 
p>.05).  Current frequency or quantity of alcohol consumption were also not 
associated with any of the IST measures.  However, a later age of onset of first (but 
not regular) alcohol use in the cannabis group was associated with a greater number of 
boxes opened in the fixed win condition and fewer sampling errors in the decreasing 
win condition.  Age of onset of regular alcohol use in the cannabis group was not 
associated with any IST performance measures.  
 
Partial Correlations between various Cannabis Measures 
Partial correlations were performed between various cannabis use measures to 
determine their relative effects on IST performance, concentrating on the primary 
outcome measure of P(Correct).  As shown in Table 5, the association between 
P(Correct) and age of onset of cannabis use and duration of cannabis use remained 
significant after controlling for measures of recent cannabis use (self-reported hours 
since last use, salivary and urinary cannabinoids).  This suggests a greater influence 
on performance of longer duration cannabis use commencing at an early age, rather 




between hours since last use, salivary or urinary cannabinoids and P(Correct) after 
controlling for age of onset and duration of cannabis use.  Further, a specific effect of 
early onset and long duration cannabis use over and above recent use was determined 
by showing that their association with P(Correct) remained after controlling for 
current levels of exposure to cannabis (quantity and frequency per month), but not the 
reverse (i.e., no associations between current quantity and frequency of cannabis use 
remained with P(Correct) after controlling for age of onset and duration of use).  
 
Table 5 about here 
 
Recent Other Drug Use 
Within the cannabis group, 27% of participants had used ecstasy in the past 30 
days, as had one of the alcohol users.  The number of pills consumed in the past 30 
days was used as a covariate in the analysis.  The main effect of group for P(Correct) 
(F(2,171)=6.94, p=0.001) and for number of boxes opened (F(2,171)=5.49, p=0.005) 
remained significant with the poorest performance in cannabis users compared to both 
alcohol users (p<0.01) and controls (p<0.05), after controlling for ecstasy use. 
Cannabis users who had consumed other drugs (including ecstasy, 
amphetamine, cocaine and hallucinogenic mushrooms) in the past 30 days (n=13) 
were then compared to those cannabis users who had not used any other drugs aside 
from cannabis and alcohol in the past 30 days (n=35).  There were no differences 
between the two groups for P(Correct) (F(1,46)=0.48, p=0.49) or number of boxes 
opened (F(1,46)=0.002, p=0.96), and no differences between groups on any other IST 
measure (all p>0.28).  Therefore, other recent drug use did not affect IST performance 







The results of this study demonstrate impairment in the ability to gather and 
evaluate information prior to decision making in a sample of adolescent cannabis 
users.  These young cannabis users were impaired on most IST performance outcome 
measures and our findings suggest greater impairment following early initiation and 
prolonged exposure to cannabis use over and above recent exposure.  We 
demonstrated a specific association with cannabis rather than alcohol or other 
concomitant drug use.  
The adolescent cannabis users sampled to a lower probability of certainty, made 
faster (more impulsive) decisions, and made more discrimination errors.  The majority 
of these deficits remained significant after controlling for recent ecstasy use, alcohol-
related problems, tobacco use, apathy and psychological symptoms (depression and 
state anxiety), and age and gender differences between groups.  These findings 
suggest poor reflection and decision making at a lower level of certainty in adolescent 
cannabis users relative to adolescent alcohol users and non-substance-using controls.   
The majority of IST performance outcome measures worsened with an earlier 
age of onset of cannabis use and longer duration of use.  The earlier that these young 
users initiated regular cannabis use and the longer the term of their exposure, the more 
likely they were to open fewer boxes, have faster box opening latencies, and have a 
lower probability of being correct at the point of decision.  Greater sampling and 
discrimination errors were also associated with an earlier age of onset of use and 
longer exposure to cannabis.  This was particularly evident in the fixed win condition.   
Greater frequency and quantity of cannabis use per month were associated with 
more discrimination errors, and frequency was also associated with lower P(correct).  




logically based on the evidence available.  This might suggest that impaired decision 
making is related to current use of cannabis, but partial correlational analyses revealed 
a specific effect of earlier age of onset and duration of use on IST performance after 
controlling for current use, and not the reverse.  No significant associations between 
IST performance and current cannabis use remained after controlling for age of onset 
and duration of cannabis use.  Further, impaired performance could not be attributed 
to acute intoxication or withdrawal symptoms – 54.3% of the cannabis sample had 
zero THC levels detected in saliva and a further 28.3% had levels less than 1ng/ml, 
and no performance measures correlated with withdrawal scores.    
As the IST puts minimal demands on working memory (Clark et al. 2006), these 
findings do not reflect a simple deficit in working memory in the young cannabis 
users of this study.  Despite a lack of condition by group interactions, the majority of 
significant associations with cannabis use measures were in the fixed win condition, 
where there were no losses contingent upon performance.  The introduction of 
negative reinforcement (i.e., losing points in the decreasing win condition) may 
override some of the effects of cannabis on impulsive tendencies and adolescent 
cannabis users may need more motivation to self-regulate these.  Our findings of 
impaired reflection impulsivity in adolescent cannabis users, with perhaps greater 
effects in the fixed win condition, are similar to those reported by Clark et al. (2009) 
in a sample of young adult cannabis users, as well as in opiate and amphetamine users 
(Clark et al. 2006).  However, this study did find that the implementation of a loss 
condition modified adolescent cannabis users’ risky behaviour.  This is in contrast to 
Fridberg et al. (2010) who found that adult cannabis users were less sensitive to loss 
on the IGT than controls and were also more motivated by immediate reward.  




average of 13 years, while our relatively novice sample had been using regularly for 
just over 2 years.  Therefore, it may be that at a relatively young stage of cannabis use 
without the development of dependence, adolescents may respond to loss with 
reductions in impulsive behaviour.  However, if cannabis use is continued over time 
and with the development of dependence, they may be less likely to respond to these 
cues and will show more consistently risky and impulsive behaviour, regardless of 
consequence.  If the tendency toward risky decision making could be modified at an 
early stage, then this may have benefits for future outcomes not only in a cognitive 
domain but also for future risky and impulsive behaviour such as unsafe sex, 
experimentation with other drugs and heavy drinking.   
The current sample of adolescent users commenced cannabis use between the 
ages of 15 and 16 years.  This is a period characterised by neurodevelopmental 
changes where the brain is undergoing significant resculpting, synaptic pruning and 
ongoing myelination (Paus 2005; Schepis et al. 2008; Schneider 2008).  The 
prefrontal cortex together with its connections with the amygdala and striatum have 
been implicated in the neurocircuitry of cognitive and affective decision making 
(Clark et al. 2004; Ernst and Paulus 2005; Krain et al. 2006).  Recent neuroimaging 
studies have demonstrated structural alterations (Lorenzetti et al. 2010; Yücel et al. 
2008; Yücel et al. 2010) and altered activation patterns (Nestor et al. 2010; Wesley et 
al. 2011) in these brain regions in long-term cannabis users.  Further investigation into 
the mechanisms that may potentially underlie the current findings is warranted to 
determine the impact of cannabis on the developing adolescent brain.  That the 
adolescent brain may be more vulnerable to cannabis insult was highlighted in our 
introduction.  We have reported greater adverse effects on verbal learning and 




evidence for greater adverse effects of cannabis on reflection impulsivity in 
adolescence, in that our results from a young sample with relatively few years and less 
monthly exposure to cannabis (approximately 17 joints per month) are comparable to 
those of Clark et al’s  (2009) study of young adults using 31.3 joints per month.  
Poorer reflection impulsivity in cannabis-using adolescents might also be 
subserved by an altered serotonergic system.  The serotonergic system has been 
implicated in the regulation of impulse control, behavioural inhibition and effective 
decision-making (Evenden 1999b; Clark et al. 2004; Soubrié 1986), with reductions 
in serotonin (5-hydroxytryptamine, 5-HT) levels being associated with reduced 
inhibitory control and increases in impulsive behaviour (Clark et al. 2009; Evenden 
1999b). Cannabinoids have been shown to interact with 5-HT receptors (Kelaï et al. 
2006; Kimura et al. 1998) and evidence from preclinical studies suggests the 
involvement of cannabinoid receptors (CB1) in the regulation of serotonergic 
responses (Lau and Schloss 2008; Mato et al. 2007), whereby stimulation of CB1 
receptors reduces (Balazsa et al. 2008) and inhibits (Best and Regehr 2008; Nakazi et 
al. 2000) 5-HT release. Administration of THC has been shown to decrease 
serotonergic activity in various brain regions in animal studies (Molina-Holgado et al. 
1993; Moranta et al. 2004; Sagredo et al. 2006). Chronic exposure to cannabinoids 
during adolescence has similarly been shown to attenuate serotonergic activity 
(Bambico et al. 2010) and differentially affect 5-HT1A receptor binding and mRNA 
expression in adult versus adolescent brains (Zavitsanou et al. 2009).   
The limitations of our study include the lack of available promorbid ability 
scores for a portion of the sample, the recruitment of the larger portion of the sample 
of adolescent cannabis users from outside of the longitudinal cohort from which 




the control group.  We accounted for the majority of these limitations, as well as 
differences between groups in other substance use, in the analyses conducted and do 
not believe that they impact upon our results in any substantial way.  While the small 
sample size for those consuming other drugs in the past 30 days may render those 
analyses underpowered to detect a difference between groups, the level of recent (and 
indeed) other drug use was in any case low in the sample (Table 2).  Our 
interpretations of the findings would, however, have been aided by pre-cannabis 
exposure measures of impulsivity and decision-making.  For example, it is possible, 
that the cannabis users were more impulsive than the non-cannabis using groups prior 
to cannabis exposure.  Such pre-existing intrinsic impulsivity may have resulted in 
both the ultimate use of cannabis, as well as an earlier initiation of cannabis use.  
Therefore, caution should be taken when interpreting these findings in direct 
association with cannabis exposure per se.  A further limitation may be that the IST 
was the final test in a battery of cognitive tasks administered in the same order to all 
groups and lasting approximately one hour.  It is possible that sustained vigilance may 
be worse in cannabis users than in alcohol users and controls, which could lead to 
greater fatigue effects in this group when performing the IST.  Effects of fatigue, 
effort and motivation in cannabis users could be further explored in relation to 
reflection impulsivity, and particularly within tasks that include actual rewards and 
punishment (e.g., monetary gains and losses).  Further research could examine the 
trajectory and nature of impulsive behaviours in the context of losses as cannabis 
dependence develops, and determine the impact of ongoing cannabis use or cessation 
of use in the context of the maturing adolescent brain.   
In conclusion, regular adolescent cannabis users show deficits in reflecting on 




appears to be associated more with cannabis use when there are no negative 
consequences, but is impaired in conditions both with and without negative 
consequences.  Poor reflection impulsivity was associated with greater exposure to 
cannabis and a younger age of onset, after controlling for both current and recent 
cannabis use, and was not associated with alcohol use during adolescence nor 
exposure to other drugs.  Our findings have implications for the development of 
interventions aimed at reducing impulsive and risky behaviour among young cannabis 
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Table 1. Demographic and clinical characteristics of the sample: mean (SD) or median [range] 
 






p (three-group comparison) p (Cann vs. Alc) 
Gender (M/F) 27/21  34/31 18/44  <0.01 0.68 
Age 18.6 (0.8) 18.3 (0.5) 18.1 (0.5) <0.001 <0.01 
IQa 103.9 (14.2) 104.7 (12.2) 104.6 (10.3) 0.93 0.93 
Premorbid verbal ability 90.1 (6.5) 92.4 (5.7) 91.3 (5.2) 0.24 0.22 
Premorbid numerical ability 86.5 (7.3) 89.8 (6.5) 87.0 (7.3) 0.08 0.14 
State anxiety 32.5 [23-54] 30 [20-56] 27.5 [20-45] <0.01 0.98 
Trait anxiety 39.2 (9.5) 36.5 (9.0) 34.9 (9.0) 0.06 0.28 
Apathy Evaluation Scale 11 [2-29] 8 [0-31] 7 [0-31] <0.001 <0.01 
Beck Depression Inventory 6 [0-34] 4 [0-32] 3 [0-23] <0.01 0.08 
Kessler Psychological Distress 17.9 (4.7) 17.2 (4.3) 16.3 (4.2) 0.15 0.63 
a From WASI short version; Premorbid verbal ability scores available for 24 cannabis users, 48 alcohol users, 45 controls; Premorbid numerical ability scores 




Table 2. Substance use characteristics of the sample: mean (SD) or median [range] 
 
 Cannabis Users Alcohol Users Controls p (Cann vs. Alc) 
Age of First Cannabis Use 15 [9-18] 17 [15-18.8]a 16 [14-17]a <0.001 
Age of Regular Cannabis Use 16.5 [12.5-18.8] - - - 
Duration of Regular Cannabis Use (years) 2.3 (1.2) - - - 
Frequency of Cannabis Use (days/month) 10.8 [0.5-30] 0 0 - 
Quantity of Cannabis Use (cones/month)b 50 [3.5-1517.5] 0 0 - 
Last Use of Cannabis (hours ago) 22.5 [12-2760] - - - 
Urinary THC-COOH (ng/mg) 84 [0-4335] 0 0 - 
Salivary THC (ng/ml) 0 [0-7.2] 0 0 - 
Severity of Dependence (cannabis) 2 [0-14] - - - 
Age of First Alcohol Use 15 [10-17] 15.5 [7-18] 16 [10-18] <0.01 
Age of Regular Alcohol Use 16 [12-18] 17 [14-18.5] - <0.001 




Frequency of Alcohol Use (days/month) 4 [0-12.5] 5 [2-12.33] 1.5 [0-4] 0.13 
Quantity of Alcohol (std drinks/month) 35.6 [0-155] 27.6 [9.23-241.7] 3.2 [0-17.7] 0.63 
Last Use of Alcohol (hours ago) 125 [17-3240] 84 [10-768] 134 [0-2880] <0.05 
AUDIT Total Score 12 [0-26] 9 [3-27] 2 [0-11] <0.05 
Cigarettes per day 1 [0-12.5] 0 [0-8.6] 0 [0] <0.001 
Lifetime Occasions of Illicit Substance usec 4 [0-123] 0 [0-8] 0 [0-1] <0.001 
a 19 of the alcohol users had tried cannabis, 5 controls had tried cannabis  
b Approximately 16.7 joints per month 





Table 3. Group differences on IST measures of reflection impulsivity: mean (SD) or median [range]; 3 group comparison and subgroup comparisons 
 
FW Fixed win condition; DW Decreasing win condition











P(Correct) FW 0.79 (0.11) 0.85 (0.11) 0.85 (0.10) <0.01 <0.01 <0.01 1.00 
P(Correct) DW 0.68 (0.07) 0.71 (0.09) 0.72 (0.07) <0.05 <0.05 0.07 0.97 
Boxes opened per trial FW 14.32 (5.79) 17.02 (5.54) 16.06 (5.34) <0.05 0.23 <0.05 0.60 
Boxes opened per trial DW 7.65 (3.16) 9.36 (4.07) 9.02 (3.64) <0.05 0.13 <0.05 0.86 
Discrimination errors FW 1 [0-5] 0 [0-3] 0 [0-2] <0.01 <0.01 <0.05 0.31 
Discrimination errors DW 1 [0-6] 1 [0-5] 0 [0-3] 0.20 0.09 0.52 0.22 
Box opening latency FW ms 583 [237-1194] 568 [229-2650] 655 [265-2001] 0.37 0.46 0.63 0.16 
Box opening latency DW ms 1139 [360-2594] 878 [226-2428] 1021 [527-2604] 0.07 0.31 <0.05 0.12 
Colour decision latency FW s 10700 [3761-19564] 11946 [5030-35341] 11291 [4980-35343] <0.05 <0.05 <0.05 0.78 



























Age first can 
use  
.39** .22 .33* .16 -.35* -.12 -.26 -.21 -.25 
Age regular 
can use 
.42** .13 .37* .09 -.32* -.23 -.42** -.12 -.38** 
Duration 
regular use 
-.46** -.17 -.38* -.14 .31* .04 .48** .27 .39** 
Cannabis 
frequency 
-.30* -.14 -.20 .01 .02 -.09 .36* .42** .26 
Cannabis 
quantity 
-.23 -.15 -.08 .11 .11 -.09 .43** .44** .30* 
Hours since 
last use 
.02 -.09 -.08 -.14 .16 .10 -.35* -.20 -.21 
Salivary THC -.10 .21 .22 .23 -.40 -.26 .56•• -.06 .02 
Urinary 
cannabinoids 
-.37** -.23 -.25 -.07 .19 -.02 .36* .45** .41** 
Cannabis 
dependence 
-.03 .01 .02 .05 .04 .06 .18 .19 .11 
Cannabis 
withdrawal 
-.17 -.02 -.15 .10 .17 -.06 .22 .13 .15 
Age first alc 
use 
.25 .13 .32* .20 -.29 -.31* -.16 .15 -.18 
Age regular 
alc use 
.13 -.04 .15 .02 -.20 .03 -.19 -.01 -.04 







-.04 -.21 .04 -.15 .10 .03 -.14 -.07 -.01 




Table 5. Partial correlations between cannabis use measures and IST performance (P(Correct) collapsed across FW and DW conditions): partial 
r.  
 
  P(Correct) 
Controlling for recent cannabis use and cannabinoid levelsa   
 Age of first cannabis use 0.44** 
 Age of regular cannabis use 0.30* 
 Duration of regular cannabis use -0.35* 
 Cannabis frequency -0.23 
 Cannabis quantity -0.11 
Controlling for age of onset and duration of regular use   
 Hours since last use -0.07 
 Urinary cannabinoid level -0.17 
 Salivary THC level -0.02 
 Cannabis frequency -0.09 
 Cannabis quantity -0.09 
Controlling for frequency and quantity of cannabis use   
 Age of first cannabis use 0.37** 
 Age of regular cannabis use 0.25* 
 Duration of regular cannabis use -0.27* 
FW Fixed win condition; DW Decreasing win condition 
a Recent cannabis use as self-reported hours since last use, cannabinoid metabolite levels in urine and salivary THC 








Fig. 1  Mean probability of being correct at the point of decision (P(correct)) in fixed 
win and decreasing win conditions for adolescent cannabis users, alcohol users and 
controls.  
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